Australian biopharma company Telix Pharmaceuticals Limited is expanding its artificial intelligence (AI) capability with the signing of an agreement to acquire Austria-based Dedicaid GmbH, a spin-off of the Medical University Vienna.Dedicaid’s core asset is a clinical decision support software…
Source: www.labiotech.eu – Read more

How CISOs Can Successfully Lead Security Transformation in Hybrid Work Environments
CISOs face challenges in hybrid work models, requiring a shift from traditional security to a dynamic approach. They must lead cultural change, engage with leadership,